Devon J. Shedlock

Devon J. Shedlock

Hoofd Techniek/Wetenschap/O&O bij POSEIDA THERAPEUTICS, INC.

Consumer Services
Health Technology

Oorsprong van het eerstegraads netwerk van Devon J. Shedlock

EntiteitType entiteitIndustrie
Public Company Biotechnology 15

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Devon J. Shedlock via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
University of San Diego College/University

John Schmid

Johanna Mylet

Masters Business Admin

Undergraduate Degree

Medical Specialties

Marcea Lloyd

Mark Gergen

Corporate Officer/Principal

Corporate Officer/Principal

Medical/Nursing Services

Cynthia Collins

Kristin Yarema

Director/Board Member

Director/Board Member

HALOZYME THERAPEUTICS, INC. Biotechnology

Harry Leonhardt

Mark Gergen

Compliance Officer

Chief Operating Officer

College/University

Harry Leonhardt

Loren Wagner

Graduate Degree

Graduate Degree

MIRATI THERAPEUTICS Biotechnology

Mark Gergen

Charles Baum

Chief Operating Officer

Chief Executive Officer

Packaged Software

Charles Baum

Chairman

PMV PHARMACEUTICALS, INC. Miscellaneous Commercial Services

Charles Baum

Director/Board Member

Packaged Software

Charles Baum

Director/Board Member

PFIZER, INC. Pharmaceuticals: Major

Charles Baum

Corporate Officer/Principal

ACRIVON THERAPEUTICS, INC. Pharmaceuticals: Major

Charles Baum

Director/Board Member

Pharmaceuticals: Major

Charles Baum

Director/Board Member

GSK PLC Pharmaceuticals: Major

Rafael Amado

Corporate Officer/Principal

IMMUNOMEDICS, INC. Biotechnology

Charles Baum

Director/Board Member

Washington University School of Medicine College/University

Charles Baum

Doctorate Degree

ARRAY TECHNOLOGIES, INC. Pharmaceuticals: Major

Charles Baum

Director/Board Member

University of Seville College/University

Rafael Amado

Doctorate Degree

XERIS BIOPHARMA HOLDINGS, INC. Biotechnology

John Schmid

Director/Board Member

DESIGN THERAPEUTICS, INC. Biotechnology

John Schmid

Director/Board Member

Pharmaceuticals: Major

John Schmid

Director/Board Member

Pharmaceuticals: Major

John Schmid

Director/Board Member

ANAPTYSBIO, INC. Biotechnology

John Schmid

Director/Board Member

NEOS THERAPEUTICS, INC. Pharmaceuticals: Major

John Schmid

Director/Board Member

Miscellaneous Commercial Services

John Schmid

Chairman

AUSPEX PHARMACEUTICALS INC Pharmaceuticals: Major

John Schmid

Director of Finance/CFO

ADAPTIMMUNE THERAPEUTICS PLC Biotechnology

Rafael Amado

Chief Tech/Sci/R&D Officer

ALLOGENE THERAPEUTICS, INC. Biotechnology

Rafael Amado

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Rafael Amado

Corporate Officer/Principal

Stanford University College/University

Kristin Yarema

Undergraduate Degree

Michigan State University College/University

Lisa Portale

Undergraduate Degree

Electronic Equipment/Instruments

Karen Basbaum

Corporate Officer/Principal

Drugstore Chains

Karen Basbaum

Corporate Officer/Principal

University of North Dakota College/University

Karen Basbaum

Undergraduate Degree

Rensselaer Polytechnic Institute College/University

Karen Basbaum

Graduate Degree

Paul Merage School of Business College/University

Karen Basbaum

Masters Business Admin

Investment Managers

Luke Corning

Corporate Officer/Principal

TLP Trading LLC

Luke Corning

Corporate Officer/Principal

Miami University College/University

Luke Corning

Undergraduate Degree

MALIN CORPORATION PLC Biotechnology

Luke Corning

Director/Board Member

AMGEN INC. Pharmaceuticals: Major

Kristin Yarema

Corporate Officer/Principal

Celiac Disease Foundation

Kristin Yarema

Director/Board Member

University of California, Berkeley College/University

Kristin Yarema

Doctorate Degree

Statistieken

Internationaal

Verenigde Staten 44
Verenigd Koninkrijk 4
Spanje 2
Ierland 2

Sectoraal

Health Technology 24
Consumer Services 12
Finance 5
Commercial Services 5
Technology Services 3

Operationeel

Director/Board Member 52
Corporate Officer/Principal 34
Independent Dir/Board Member 21
Undergraduate Degree 12
General Counsel 12
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU